Thoracoscopic Ablation for Lone Atrial Fibrillation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 232 participants.
Also called NCT05708027
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 232 participants
- Sponsor
- Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
- Registry
-
NCT05708027
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Unknown status
Technical summary
Registry record NCT05708027. Non-randomized; no masking; primary purpose treatment. Start 2021-01-06 (actual); primary completion 2022-08-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Thoracoscopic Ablation for Lone Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Condition
- Heart Diseases
- Intervention (Procedure)
- Thoracoscopic surgical ablation
- Lead sponsor
- Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
- Collaborator
- Federal State Budget Institution Clinical Hospital, Moscow, Russia
Record details
- Record id
cardio:ct-nct05708027- Content hash
beeabffacbe2a213fbffd94f8e1d6a5d80935a7f6147d28716e4265e01b621ed